These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23708663)

  • 1. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
    Martin D; Nguyen Q; Molinolo A; Gutkind JS
    Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
    Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S
    Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.
    Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS
    Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
    Sodhi A; Montaner S; Gutkind JS
    FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma.
    Montaner S
    Cell Cycle; 2007 Feb; 6(4):438-43. PubMed ID: 17329974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma.
    Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S
    PLoS One; 2011 Apr; 6(4):e19103. PubMed ID: 21559457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.
    Chaisuparat R; Hu J; Jham BC; Knight ZA; Shokat KM; Montaner S
    Cancer Res; 2008 Oct; 68(20):8361-8. PubMed ID: 18922908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
    Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
    Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma virally encoded, G-protein-coupled receptor: a paradigm for paracrine transformation.
    Martin D; Gutkind JS
    Methods Enzymol; 2009; 460():125-50. PubMed ID: 19446723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classic Kaposi's sarcoma treated with topical rapamycin.
    Díaz-Ley B; Grillo E; Ríos-Buceta L; Paoli J; Moreno C; Vano-Galván S; Jaén-Olasolo P
    Dermatol Ther; 2015; 28(1):40-3. PubMed ID: 25314592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
    Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
    Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3Kγ mediates kaposi's sarcoma-associated herpesvirus vGPCR-induced sarcomagenesis.
    Martin D; Galisteo R; Molinolo AA; Wetzker R; Hirsch E; Gutkind JS
    Cancer Cell; 2011 Jun; 19(6):805-13. PubMed ID: 21665152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.
    Montaner S; Sodhi A; Molinolo A; Bugge TH; Sawai ET; He Y; Li Y; Ray PE; Gutkind JS
    Cancer Cell; 2003 Jan; 3(1):23-36. PubMed ID: 12559173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation of KSHV encoded vGPCR functions in its signaling and tumorigenicity.
    Wu H; Liu L; Xiao J; Chi M; Qu Y; Feng H
    Viruses; 2015 Mar; 7(4):1627-41. PubMed ID: 25835533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene.
    Jham BC; Montaner S
    J Cell Biochem; 2010 May; 110(1):1-9. PubMed ID: 20213674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells.
    Cannon ML; Cesarman E
    Oncogene; 2004 Jan; 23(2):514-23. PubMed ID: 14724579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt pathway protein expression in gastrointestinal Kaposi sarcomas: relevance for tumor biology.
    Badescu A; Couvelard A; Handra-Luca A
    APMIS; 2014 Jun; 122(6):518-25. PubMed ID: 24286304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
    Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
    Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.